Market Research Logo

Global Drug Device Combination Products Market 2015-2019

Global Drug Device Combination Products Market 2015-2019

About drug device combination products

Drug device combination products consist of two regulated components: an active pharmaceutical ingredient and a medical device. These two standardized components are combined, either chemically or physically for developing one component. The drugs present in the device are either impregnated or surface coated. The drug device combination products are considered to be highly innovative in the area of advanced healthcare such as biomedical nanotechnology and development of regenerative medicine.

Technavio's analysts forecast the global drug device combination products market to grow at a CAGR of 11.95% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the global drug device combination products market for 2015-2019. The market can be segmented by product type:

  • Drug eluting stent
  • Prefilled syringes
  • Wearable injectors
  • Insulin delivery systems
Technavio's report, Global Drug Device Combination Products Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global drug device combination products market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
  • Americas
  • APAC
  • EMEA
Key vendors
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Boston Scientific
  • Medtronic
  • Roche Diagnostics
Other prominent vendors
  • Aerogen
  • Airon
  • Allied Healthcare Products
  • AstraZeneca
  • B. Braun Medical
  • BIOTRONIK
  • Boehringer Ingelheim
  • Briggs Healthcare
  • C.R. Bard
  • Cardinal Health
  • Clement Clarke International
  • Concordia
  • Consort Medical
  • Cook Medical
  • DeVilbiss Healthcare
  • Ethicon
  • Gerresheimer
  • GlaxoSmithKline
  • Heyer Medical
  • Invacare
  • Lepu Medical Technology
  • Mallinckrodt
  • Medline Industries
  • MicroPort Scientific
  • Mylan
  • Nypro
  • Omron Healthcare
  • PARI Medical
  • Phillips Healthcare
  • RPC Bramlage
  • Salter Labs
  • Smart inhaler
  • Stryker
  • Sunovion Pharmaceuticals
  • Teleflex
  • Terumo
  • Vortran Medical
  • W. L. Gore & Associates
Key market driver
  • Use of home healthcare devices
  • For a full, detailed list, view our report
Key market challenge
  • High spending by patients
  • For a full, detailed list, view our report
Key market trend
  • Use of bioabsorable stents
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Drug Device Combination Products Market 2015-2019

Technavio recognizes the following companies as the key players in the Global Drug Device Combination Products Market: Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific, Medtronic and Roche Diagnostics

Other Prominent Vendors in the market are: Aerogen, Airon, Allied Healthcare Products, AstraZeneca, Boehringer Ingelheim, B. Braun Medical, Briggs Healthcare, BIOTRONIK, Cook Medical, Cardinal Health, Consort Medical, Clement Clarke International, Concordia, C.R. Bard, DeVilbiss Healthcare, Ethicon, GlaxoSmithKline, Gerresheimer, Heyer Medical, Invacare, Lepu Medical Technology, MicroPort Scientific, Mylan, Medline Industries, Mallinckrodt, Nypro, Omron Healthcare, PARI Medical, Phillips Healthcare, RPC Bramlage, Salter Labs, Smart inhaler, Stryker, Sunovion Pharmaceuticals, Teleflex, Terumo, Vortran Medical, and W. L. Gore & Associates.

Commenting on the report, an analyst from Technavio’s team said: “One of the major trend is the use of bioabsorbable stents for treating arterial blockages. These stents have the ability to dissolve completely, over the course of time, by the formation of human cells around them. Other trends witnessed by the market are an increase in online marketing services and the growing popularity of hybrid procedures.”

According to the report, use of home healthcare devices will be one of the major drivers contributing to market growth during the forecast period. The shift of patient care from hospital settings toward homecare, especially for the elderly population, is rising gradually. This is fueled by an increase in the geriatric population, older people being prone to respiratory and cardiovascular diseases. This factor will contribute to market growth largely.

Further, the report states that one of the major challenges faced by the market is continuous spending by patients for therapy, which reduces the adoption of drug device combination products by consumers in homecare settings and therefore customers such as diagnostic centers.

Companies Mentioned

Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific, Medtronic, Roche Diagnostics, Aerogen, Airon, Allied Healthcare Products, AstraZeneca, Boehringer Ingelheim, B. Braun Medical, Briggs Healthcare, BIOTRONIK, Cook Medical, Cardinal Health, Consort Medical, Clement Clarke International, Concordia, C.R. Bard, DeVilbiss Healthcare, Ethicon, GlaxoSmithKline, Gerresheimer, Heyer Medical, Invacare, Lepu Medical Technology, MicroPort Scientific, Mylan, Medline Industries, Mallinckrodt, Nypro, Omron Healthcare, PARI Medical, Phillips Healthcare, RPC Bramlage, Salter Labs, Smart inhaler, Stryker, Sunovion Pharmaceuticals, Teleflex, Terumo, Vortran Medical, W. L. Gore & Associates.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Offerings of the top vendors
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
      • Table Global drug device combination products market
    • Market size and forecast
      • Table Global drug device combination products market 2014-2019 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • Table Segmentation of global drug device combination products market by product type
    • Table Segmentation of global drug device combination products market by product type 2014
    • Table Segmentation of global drug device combination products market by product type 2019
    • Table Segmentation of global drug device combination products market by product type 2014-2019
    • Drug-eluting stents
      • Table Global drug device combination products market in drug-eluting stent segment 2014-2019 ($ billions)
    • Prefilled syringes
      • Table Global drug device combination products market in prefilled syringe segment 2014-2019 ($ billions)
    • Wearable injectors
      • Table Global drug device combination products market in wearable injector segment 2014-2019 ($ billions)
    • Insulin delivery systems
      • Table Global drug device combination products market in insulin delivery system segment 2014-2019 ($ billions)
  • Geographical segmentation
    • Global drug device combination products market by geographical segmentation
      • Table Segmentation of global drug device combination products market by geography 2014
      • Table Segmentation of global drug device combination products market by geography 2019
      • Table Segmentation of global drug device combination products market by geography 2014-2019
    • Drug device combination products market in Americas
      • Table Drug device combination products market in Americas 2014-2019 ($ billions)
    • Drug device combination products market in EMEA
      • Table Diseases and mortality in Europe 2011
      • Table Drug device combination products market in EMEA 2014-2019 ($ billions)
    • Drug device combination products market in APAC
      • Table Drug device combination products market in APAC 2014-2019 ($ billions)
  • Market drivers
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Table Companies developing bioabsorbable drug-eluting stents
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2014
      • Table Abbott Diagnostics: Key takeaways
      • Table BD: Key takeaways
      • Table Boston Scientific: Key takeaways
      • Table Medtronic: Key takeaways
      • Table Roche Diagnostics: Key takeaways
    • Other prominent vendors
  • Key vendor analysis
    • Abbott Diagnostics
    • Becton, Dickinson and Company
      • Table BD: Business segmentation 2014 by revenue
      • Table BD: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table BD: Geographical segmentation by revenue 2014
    • Boston Scientific
      • Table Boston Scientific: Business segmentation by revenue 2014
      • Table Boston Scientific: Business segmentation by revenue 2013 and 2014 ($ billions)
    • Medtronic
      • Table Medtronic: Business segmentation by revenue 2015
    • Roche Diagnostics
      • Table Roche Diagnostics: Business segmentation by revenue 2014
      • Table Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Roche Diagnostics: Geographical segmentation by revenue 2014
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report